PODD Jul 2025 260.000 call
| Previous close | 15.00 |
| Open | N/A |
| Bid | 12.20 |
| Ask | 14.50 |
| Strike | 260.00 |
| Expiry date | 2025-07-18 |
| Day's range | 15.00 - 15.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Business WireInsulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
ACTON, Mass., June 21, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared positive results from its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) type 2 diabetes pivotal trial at the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, Florida. This landmark study evaluated the impact of AID in a diverse group of people with type 2 diabetes who req
Insider MonkeyInsulet (PODD) Faces Increasing Competition
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]
ZacksInsulet (PODD) Unveils Key Achievements for the Omnipod 5 System
Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
